Erin K. Brenner

Chief Product Dev. Officer, Pear Therapeutics (United States).

Companies

Pear Therapeutics (United States)Chief Product Dev. Officer Dec 7, 2021 to Feb 17, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pear Therapeutics (United States)43,310 shares²Jan 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 20, 2023Sold 8,690 shares at $1.13 of Pear Therapeutics (United States)²
Jan 14, 2023Exercised options 22,000 shares of Pear Therapeutics (United States)³
Dec 9, 2022Exercised options 15,000 shares at $1.00 of Pear Therapeutics (United States)⁴
May 25, 2022Exercised options 15,000 shares at $1.00 of Pear Therapeutics (United States)⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPear Therapeutics (United States), Chief Product Dev. Officer
2
SEC EDGARPear Therapeutics (United States) shares after the filing of Jan 20, 2023
3
SEC EDGARForm 4 filed Jan 18, 2023
4
SEC EDGARForm 4 filed Dec 9, 2022
5
SEC EDGARForm 4 filed May 27, 2022